HomeDYN • NASDAQ
add
Dyne Therapeutics Inc
Previous close
$17.69
Day range
$17.60 - $19.58
Year range
$6.36 - $25.00
Market cap
3.13B USD
Avg Volume
2.02M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 116.13M | 19.59% |
Net income | -111.96M | -25.03% |
Net profit margin | — | — |
Earnings per share | -0.73 | 17.05% |
EBITDA | -115.61M | -19.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.11B | 72.91% |
Total assets | 1.19B | 71.72% |
Total liabilities | 214.83M | 249.91% |
Total equity | 972.13M | — |
Shares outstanding | 165.03M | — |
Price to book | 3.00 | — |
Return on assets | -28.27% | — |
Return on capital | -29.72% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -111.96M | -25.03% |
Cash from operations | -111.83M | -32.60% |
Cash from investing | 982.00K | 106.13% |
Cash from financing | 430.96M | 11,752.72% |
Net change in cash | 320.12M | 431.01% |
Free cash flow | -74.14M | -31.99% |
About
Founded
2017
Headquarters
Website
Employees
258
